A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

Clinical trial NCT01541007 · COMPLETED

Trial details

NCT number: NCT01541007
Sponsor: Jeffrey Yachnin M.D., PhD.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer

Start date: 2012-04-01
Primary completion: 2015-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.